These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 24705684)
1. Drug company boards often include academic medical center officials, says US study. McCarthy M BMJ; 2014 Apr; 348():g2575. PubMed ID: 24705684 [No Abstract] [Full Text] [Related]
2. Academic medical center leadership on pharmaceutical company boards of directors. Anderson TS; Dave S; Good CB; Gellad WF JAMA; 2014 Apr; 311(13):1353-5. PubMed ID: 24691612 [No Abstract] [Full Text] [Related]
3. Potential conflicts of interest for academic medical center leaders. Relman AS JAMA; 2014 Aug; 312(5):558. PubMed ID: 25096701 [No Abstract] [Full Text] [Related]
4. Potential conflicts of interest for academic medical center leaders. Lechleiter JC JAMA; 2014 Aug; 312(5):558. PubMed ID: 25096700 [No Abstract] [Full Text] [Related]
5. Potential conflicts of interest for academic medical center leaders--reply. Anderson TS; Good CB; Gellad WF JAMA; 2014 Aug; 312(5):558-9. PubMed ID: 25096702 [No Abstract] [Full Text] [Related]
6. And another one. Healthcare exec nominated for seat on J&J board. Becker C Mod Healthc; 2005 Mar; 35(12):14-5. PubMed ID: 15801295 [No Abstract] [Full Text] [Related]
7. Serving two masters--conflicts of interest in academic medicine. Lo B N Engl J Med; 2010 Feb; 362(8):669-71. PubMed ID: 20181969 [No Abstract] [Full Text] [Related]
8. Insurer joins hospital board . . . expert questions wisdom of Beth Israel appointment. Vesely R Mod Healthc; 2007 Dec; 37(50):14. PubMed ID: 18203369 [No Abstract] [Full Text] [Related]
9. Academic medical centers and conflicts of interest. Angell M JAMA; 2006 Jun; 295(24):2848; author reply 2848-9. PubMed ID: 16804148 [No Abstract] [Full Text] [Related]
10. Academic medical centers and conflicts of interest. Brody H JAMA; 2006 Jun; 295(24):2848; author reply 2848-9. PubMed ID: 16804149 [No Abstract] [Full Text] [Related]
11. Potential conflicts. Policy group's board members sit on corporate boards. DoBias M Mod Healthc; 2005 Oct; 35(44):8-10. PubMed ID: 16300202 [No Abstract] [Full Text] [Related]
12. Docking the tail that wags the dog: banning drug reps from academic medical facilities. Millard WB Ann Emerg Med; 2007 Jun; 49(6):785-91. PubMed ID: 17536244 [No Abstract] [Full Text] [Related]
13. Conflict of interest or productive collaboration? The pharma: academic relationship and its implications for headache medicine. Finkel AG Headache; 2006; 46(7):1181-5. PubMed ID: 16866722 [No Abstract] [Full Text] [Related]
14. Successes, challenges emerge from efforts to shift away from industry-funded CME. Kuehn BM JAMA; 2010 Aug; 304(7):729-31. PubMed ID: 20716730 [No Abstract] [Full Text] [Related]
16. Divergent views on managing clinical conflicts of interest. Romano TJ Mayo Clin Proc; 2007 Aug; 82(8):1014; author reply 1014-5. PubMed ID: 17673073 [No Abstract] [Full Text] [Related]
17. Why academic medical centers should ban drug company gifts to individuals. Strong C Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327 [No Abstract] [Full Text] [Related]
18. Managing conflict of interest in clinical practice. Camilleri M; Cortese DA Mayo Clin Proc; 2007 May; 82(5):607-14. PubMed ID: 17493426 [TBL] [Abstract][Full Text] [Related]
19. Too friendly? Teaching hospitals revisit ties to pharmaceutical firms. Romano M Mod Healthc; 2003 Jul; 33(28):17. PubMed ID: 12884711 [No Abstract] [Full Text] [Related]
20. Academic medical centers' conflict of interest policies. Rothman DJ; Chimonas S JAMA; 2010 Nov; 304(20):2294-5. PubMed ID: 21098775 [No Abstract] [Full Text] [Related] [Next] [New Search]